Arkolith/Insider Trading/VERA/Form 4

Enright Patrick G

DirectorVera Therapeutics, Inc. (VERA) · full profile →Form 4 · filed Jun 25, 2025
Net Buying
Open-Market Buys
$5.3M
Open-Market Sells
$0
Net Open-Market Flow
$5.3M
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 24, 2025Buy(P)27K$22.35$605K3.6M
Jun 24, 2025Buy(P)14K$22.35$303K1.8M
Jun 23, 2025Buy(P)70K$20.87$1.5M1.8M
Jun 23, 2025Buy(P)140K$20.87$2.9M3.6M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-090110) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML